Østergren et al. conducted a comparative study examining the impact of Luteinizing Hormone-Releasing Hormone (LHRH) agonists and subcapsular orchiectomy on testosterone reduction in men with prostate cancer. The gene discussed is GNRH1; the disease is prostate carcinoma.